Islet Transplantation – from Research to Reality

This talk will provide an overview of pancreatic islet transplantation as a novel treatment for reversing unstable type 1 diabetes mellitus. It will highlight how over the last two decades, islet transplantation has moved successfully from a research option ‘at the bench’, to a nationally available treatment option ‘at the bedside’. The rationale, indications, and practical aspects of the treatment will be explained, and the current clinical outcomes will be summarised. Most importantly, the talk will provide an update of the recent advances and current ‘state of the art’ research aimed at enabling this life-changing treatment potentially to be offered to newly diagnosed children in the future.

Learning outcomes:

  • An understanding of the rationale and indications for islet transplantation for the treatment of unstable type 1 diabetes mellitus
  • An update of the latest clinical outcomes worldwide
  • An understanding of the place of islet transplantation in the current era of advanced insulin technology
  • An oversight of the most recent advances and novel research aimed at making islet transplantation available to newly diagnosed children in the future

Tuesday 29 October 2019

10:10 - 10:50

T1 Diabetes

MDT Icon Blue

Speakers

Paul Johnson
Director of Oxford Islet Transplant Programme and DRWF Islet Isolation Facility; Professor of Paediatric Surgery, University of Oxford, Consultant Paediatric Surgeon, Oxford Children’s Hospital